Paid Clinical Trials in Kentucky

Kentucky has 961 paid clinical trials enrolling now across cities including Louisville, Lexington and Edgewood. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

871 clinical trials

Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

for Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

Sites in Louisville +9 more locations

Sponsor: Airiver Medical, Inc.

Sex: All·Age: 18+

Code: NCT07290140·Recruiting·Listed Dec 2025

Apply to this trial

A Study of BI 3810944 in Patients With Advanced Cancer

for Solid Tumours

Sites in Louisville +3 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07224425·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

for Diabetes Mellitus, Type 1

Drug: Baricitinib

Sites in Louisville +5 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 1 - 35

Code: NCT07222137·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

EXoPERT EMERALD Clinical Study

for Breast Cancer

Sites in Louisville, Lexington +7 more locations

Sponsor: EXoPERT

Sex: All·Age: 45+·Accepts healthy volunteers

Code: NCT07186296·Recruiting·Listed Sep 2025

Apply to this trial

A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System

for Post Traumatic Arthritis

Sites in Louisville +4 more locations

Sponsor: Stryker Trauma and Extremities

Sex: All·Age: 21+

Code: NCT07118501·Recruiting·Listed Aug 2025

Apply to this trial

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

for Chronic Hepatitis Delta

Sites in Louisville +3 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18 - 69·Accepts healthy volunteers

Code: NCT07096193·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

for Deep Vein Thrombosis (DVT)

Sites in Edgewood +3 more locations

Sponsor: Argon Medical Devices

Sex: All·Age: 18+

Code: NCT07102160·Recruiting·Listed Aug 2025

Apply to this trial

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

for Chronic Obstructive Pulmonary Disease

Sites in Bowling Green, Owensboro +1 more location

Sponsor: Bambusa Therapeutics

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT06944925·Phase 1·Recruiting·Listed Apr 2025

Apply to this trial

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

for GEP-NET

Sites in Lexington +6 more locations

Sponsor: RayzeBio, Inc.

Sex: All·Age: 18+

Code: NCT07165132·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction

for Breast Reconstruction

Sites in Bowling Green +1 more location

Sponsor: Tela Bio Inc

Sex: Female·Age: 22 - 75

Code: NCT07135596·Recruiting·Listed Aug 2025

Apply to this trial

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

for Tumor Skin

Sites in Louisville +7 more locations

Sponsor: Obsidian Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06060613·Phase 1, Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

for Lung Neoplasm

Sites in Lexington +2 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06780098·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Study of ZW251 in Participants With Advanced Solid Tumors

for Hepatocellular Carcinoma

Sites in Louisville +7 more locations

Sponsor: Zymeworks BC Inc.

Sex: All·Age: 18+

Code: NCT07164313·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

for Squamous Non-small-cell Lung Cancer

Sites in Louisville +7 more locations

Sponsor: Alentis Therapeutics AG

Sex: All·Age: 18+

Code: NCT06747585·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

for Ovarian Cancer Recurrent

Sites in Louisville +7 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06843447·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

GORE® ENFORM Biomaterial Product Study

for Hernia, Ventral

Sites in Lexington +6 more locations

Sponsor: W.L.Gore & Associates

Sex: All·Age: 18+

Code: NCT04718168·Recruiting·Listed Jan 2021

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Louisville +12 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06004245·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

FIBERGRAFT Aeridyan Posterolateral Fusion Study

for Degenerative Spine Disease

Sites in Lexington +7 more locations

Sponsor: DePuy Synthes Products, Inc.

Sex: All·Age: 18+

Code: NCT07059065·Recruiting·Listed Jul 2025

Apply to this trial

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

for Carcinoma, Non-Small-Cell Lung

Sites in Lexington +2 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06780085·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

for Solid Tumor

Sites in Edgewood +10 more locations

Sponsor: ImmunoGenesis

Sex: All·Age: 18+

Code: NCT06014502·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

for Hemorrhage

Sites in Louisville +8 more locations

Sponsor: Corza Medical GmbH

Sex: All·Age: 1 Month+

Code: NCT06664775·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

for Cervical Squamous Cell Carcinoma

Sites in Louisville +8 more locations

Sponsor: Alentis Therapeutics AG

Sex: All·Age: 18+

Code: NCT07169734·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

for Elevated Blood Pressure

Sites in Bowling Green +9 more locations

Sponsor: Zona Health, Inc

Sex: All·Age: 22+

Code: NCT06843577·Recruiting·Listed Feb 2025

Apply to this trial

Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.

for Arthritis

Sites in Louisville +5 more locations

Sponsor: Aptis Medical

Sex: All·Age: 18 - 85·Accepts healthy volunteers

Code: NCT05796908·Recruiting·Listed Apr 2023

Apply to this trial

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

for Non-Small Cell Lung Cancer

Sites in Louisville, Lexington +4 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT05142189·Phase 1·Recruiting·Listed Dec 2021

Apply to this trial

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

for Cervical Cancer

Sites in Lexington +6 more locations

Sponsor: Orano Med Theranostics, SAS

Sex: All·Age: 18+

Code: NCT05283330·Phase 1·Recruiting·Listed Mar 2022

Apply to this trial

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

for Multiple Myeloma

Sites in Louisville +4 more locations

Sponsor: Heidelberg Pharma AG

Sex: All·Age: 18+

Code: NCT04879043·Phase 1, Phase 2·Recruiting·Listed May 2021

Apply to this trial

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

for Pediatric Chronic Inflammatory Demyelinating Polyneuropathy

Sites in Louisville +5 more locations

Sponsor: Octapharma

Sex: All·Age: 2 - 17

Code: NCT04929236·Phase 3·Recruiting·Listed Jun 2021

Apply to this trial

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Louisville +7 more locations

Sponsor: OncoC4, Inc.

Sex: All·Age: 18+

Code: NCT06352359·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

for Non-small Cell Lung Cancer

Sites in Lexington +4 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06731907·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

for Hereditary Angioedemas

Sites in Louisville +4 more locations

Sponsor: CSL Behring

Sex: All·Age: 12+

Code: NCT07001280·Recruiting·Listed Jun 2025

Apply to this trial

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

for B-cell Non-Hodgkins Lymphoma (B-NHL)

Drug: Odronextamab

Sites in Louisville +8 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05685173·Phase 1·Recruiting·Listed Jan 2023

Apply to this trial

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

for Non-small Cell Lung Cancer

Drug: Pumitamig

Sites in Elizabethtown +3 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06841055·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

MagDI U.S. Registry

for Anastomosis, Surgical

Sites in Louisville +4 more locations

Sponsor: GT Metabolic Solutions, Inc.

Sex: All·Age: 22+

Code: NCT06928545·Recruiting·Listed Apr 2025

Apply to this trial

Perform Humeral System Study

for Osteoarthritis Shoulder

Sites in Lexington +3 more locations

Sponsor: Stryker Trauma and Extremities

Sex: All·Age: 18+

Code: NCT05067543·Recruiting·Listed Oct 2021

Apply to this trial

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Louisville +6 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06750185·Phase 1·Recruiting·Listed Dec 2024

Apply to this trial

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

for Parkinson's Disease

Sites in Lexington +1 more location

Sponsor: Sumitomo Pharma America, Inc.

Sex: All·Age: 40 - 72

Code: NCT06753331·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

for Advanced Solid Tumor

Sites in Lexington +8 more locations

Sponsor: TORL Biotherapeutics, LLC

Sex: All·Age: 18+

Code: NCT05103683·Phase 1·Recruiting·Listed Nov 2021

Apply to this trial

Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee

for Osteochondral Defect

Sites in Lexington +5 more locations

Sponsor: AlloSource

Sex: All·Age: 12 - 60

Code: NCT06216756·Recruiting·Listed Jan 2024

Apply to this trial

PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery

for Homonymous Hemianopsia

Sites in Prospect +1 more location

Sponsor: NeuroAEye LLC

Sex: All·Age: 21 - 80

Code: NCT07185971·Recruiting·Listed Sep 2025

Apply to this trial